FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely to neurology, gastroenterology and microbiology, and concerns reducing the manifestations of non-motor symptoms in Parkinson's disease (PD). That is ensured by intestinal microbiocenosis correction by introducing an autoprobiotic with Enterococcus faecium content of not less than 108 KOE per 1 ml. Autoprobiotic is orally administered in dose of 50 ml 2 times a day for a course of at least 20 days.
EFFECT: it provides effective correction of non-motor PD symptoms, particularly improvement of bowel motility and evacuation capacity without side effects, due to absence of conflict with immune system, as well as with other representatives of patient's own microbiota.
1 cl, 2 ex, 3 tbl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTION POST-INFECTIOUS IRRITABLE BOWEL SYNDROME | 2014 |
|
RU2553372C1 |
| METHOD OF OBTAINING PERSONIFIED AUTOPROBIOTIC PRODUCT AND METHOD OF TREATING SYNDROME OF IRRITABLE BOWL WITH THEREOF APPLICATION | 2013 |
|
RU2546253C2 |
| METHOD FOR PREPARING AN AUTOPROBIOTIC BASED ON AN ANAEROBIC CONSORTIUM OF BACTERIA | 2018 |
|
RU2734896C2 |
| METHOD FOR MONOTHERAPY OF GASTRITIS ASSOCIATED WITH HELICOBACTER PYLORI INFECTION | 2020 |
|
RU2758246C1 |
| METHOD FOR TREATMENT OF IRRITABLE BODY SYNDROME | 2017 |
|
RU2661624C1 |
| METHOD FOR PRODUCING AUTOPROBIOTIC OF ENTEROCUCCUS FAECIUM BEING REPRESENTATIVE OF INDIGENIC HOST INTESTINAL MICROFLORA | 2010 |
|
RU2460778C1 |
| METHOD FOR RESTORING ONE'S OWN INTESTINAL MICROBIOTA AFTER ANTIBIOTIC THERAPY | 2021 |
|
RU2775887C1 |
| METHOD FOR TREATMENT OF PROLONGED COURSE OF INTESTINAL INFECTION OF CAMPYLOBACTER ETIOLOGY IN YOUNG CHILDREN | 2022 |
|
RU2788397C1 |
| METHOD FOR DETERMINING SENSITIVITY OF CAMPYLOBACTERIAE TO PROBIOTICS AND AUTOPROBIOTICS | 2022 |
|
RU2816763C1 |
| METHOD FOR TREATMENT OF FUNCTIONAL DISEASES OF GASTROINTESTINAL TRACT IN CHILDREN | 2021 |
|
RU2766765C1 |
